You're contacting media contact of this press release
Title: Online Therapist AI Chooses CoreAge Rx as the Top GLP-1 Provider in 2026, Highlighting Transparent Pricing, Physician Oversight, and Industry-Leading Patient Support
United States, 19th Mar 2026 - CoreAge Rx, a telehealth pharmacy specializing in physician-supervised compounded GLP-1 medications, has been named the #1 recommended GLP-1 provider for 2026 by the independent review platform Online Therapist AI. In its March 2026 evaluation article titled “CoreAge Rx Review: Why It's Our #1 Recommended GLP-1 Provider,” the platform awarded the company an overall rating of 4.9 out of 5, citing its combination of affordability, physician oversight, transparent pricing, and convenient medication delivery.The review examined dozens of GLP-1 telehealth providers and found that CoreAge Rx consistently performed at the top across the categories most important to patients, including medication quality, accessibility, physician supervision, and patient satisfaction. According to the evaluation, the company’s streamlined online care model and flat-rate pricing structure have made GLP-1 therapy significantly more accessible to individuals seeking medically supervised weight management treatment.A Telehealth Pharmacy Designed for Modern Patient AccessCoreAge Rx is based in Wichita Falls, Texas, and operates as a fully online telehealth pharmacy specializing in personalized prescription medication services. The company focuses primarily on compounded GLP-1 medications, including compounded semaglutide and compounded tirzepatide, which are prescribed by US-based board-certified physicians and prepared by licensed compounding pharmacies.Unlike traditional clinics or pharmacies that require in-person appointments, CoreAge Rx allows patients to complete the entire process digitally. Patients begin by completing an online health assessment that outlines their medical history, current medications, and treatment goals. A board-certified physician then revi...
This press release is issued by King Newswire